February 18, 2010 – 7:52 pm
The Healthcare Sales and Marketing Network
February 17, 2010
Investigational Data Also Presented on Efficacy Against HPV 6,11,16 and 18 – Related Persistent Infection, CIN and EGL in Women Aged 24 Through 45 Naïve to the Relevant HPV Type
In this study, 87 percent of the vaccine group and 81 percent of the placebo group reported one or more AEs. These were predominantly injection-site AEs (77 percent of the vaccine group and 64 percent of the placebo group). Serious adverse events were reported rarely and occurred comparably in the vaccine (0.7 percent) and placebo (0.8 percent) groups, and none were deemed to be vaccine-related by the study investigators.
February 17, 2010 – 7:53 pm
The Miami Herald
National Business
By LINDA A. JOHNSON
AP Business Writer
TRENTON, N.J. — The Gardasil vaccine protected most ( how many is most??) young women from cervical cancer and homosexual men from anal cancer, according to new studies released Wednesday by its maker, Merck & Co. Studies were conducted by Merck.
Comment from Leslie -the vaccine has only been on the market for 3 years so how can Merck say ANYONE has been protected from cervical cancer? NVIC lists 272 cases of abnormal pap tests post vaccination.
February 17, 2010 – 7:40 pm
PharmaNews.eu
February 15, 2010
Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program. With the EC approval, Merck receives marketing authorization for ELONVA with unified labeling valid in all European Union Member States. Schering-Plough Corp. and Merck & Co., Inc. merged on Nov. 3, 2009.
Comment from Leslie – And now Merck is coming out with an injection to stimulate ovulation? I would never take an injection from Merck or anyone else to stimulate ovulation especially if it was their initial injection (vaccine) that caused it to stop.
February 16, 2010 – 8:42 am
Star Exponent
Culpeper, VA
Melinda Weninger, Bismarck, N.D.
Published: February 16, 2010
Updated: February 16, 2010
Thank you so much for the story about Gardasil vaccination (“Local couple questions Gardasil’s safety,” Feb. 7). My daughter Jessica had the vaccination shortly after it was introduced in 2006.
She has been sick ever since. That is over three years later, and she is still suffering adverse side effects.
By Leslie Carol Botha
|
Posted in Adolescent Girls, Cervarix, Cervical Cancer, Gardasil/Silgard, Global Gardasil/Silgard Concerns, Menopause, Menstrual Cycle, Mothers & Daughters, Sexually Transmitted Diseases, Teens, Vaccinations, Women's Health, Women's History, Women's Politics
|
February 14, 2010 – 8:43 pm
Birmingham Mail
February 9, 2010
TEENAGE girls in Birmingham are being offered shopping vouchers to have the controversial HPV cervical cancer jab, it can be revealed today.
If they have the jab the teenagers each get £45 worth of Love2Shop store vouchers.
But the vouchers for jabs scheme was branded “bribery” by the mother of one teenage girl, while another described it as “unethical coercion.”
February 14, 2010 – 9:17 am
Anthrax Blogspot.com
Meryl Nass
Bar Harbor, Maine, United States
Julie Gerberding moved to Merck last month and CDC simultaneously decided to focus on cervical cancer. What a coincidence! The only cancer mentioned on CDC’s home page is cervical cancer, and a chart of cervical cancer incidence by ethnicity is the only statistical information on the home page.
February 13, 2010 – 2:06 pm
By Mary Tocco
February 13, 2010
NewsWithViews.com
Since the introduction of the Gardasil vaccine, there has been a growing concern about safety and efficacy. As our vaccine producers come up with more vaccines, we must continue to fight this theory as dangerous and unnecessary. What is a theory about the cause of cancer, having never been proven, are the grounds for this vaccine.
February 13, 2010 – 12:29 pm
Business and Human Rights Resource Centre
Saheli Women’s Resource Centre & Sama Resource Group for Women & Health [India]
Dated: 28 Dec 2009
In a public meeting…women’s groups Sama Resource Group…and Saheli Women’s Resource Centre, raised serious objections to the trials, study and marketing of HPV (human papillomavirus) vaccines claiming to protect young girls from cervical cancer in India.
February 11, 2010 – 6:55 pm
Irish Medical Times
Gary Culliton
gary.culliton@imt.ie
The contract to supply a cervical cancer vaccine which has been awarded to Sanofi Pasteur, the Minister for Health, Mary Harney, confirmed at yesterday’s meeting of the Joint Oireachtas Committee on Health.
The vaccine, Gardasil, will be given to first-year students in second-level schools this year.
February 4, 2010 – 8:34 pm
Web of Evidence
February 4, 2010
Julie Smith, researcher and founder of a New Zealand website set up specifically to give information about the HPV vaccine, Gardasil, www.offtheradar.co.nz, says concerned parents have been contacting her wanting to know how they can help to have the vaccine withdrawn from New Zealand.
After last night’s Close Up on TV 1 Ms Smith says “Many more parents are making the connection to their child’s sudden onset of deteriorating health since receiving the Gardasil vaccine.”
“What is now happening to our girls here in New Zealand is replicating what has already happened overseas. It was only a matter of time before girls here were going to die from this vaccine,” said Ms Smith.
By Leslie Carol Botha
|
Posted in Adolescent Girls, Cervarix, Cervical Cancer, Gardasil Blogs, Gardasil/Silgard, Global Gardasil/Silgard Concerns, Human Papillomavirus, Mothers & Daughters, Social/Political, Teens, Vaccinations, Women's Health, Women's Politics
|
BlogoSquare